$ONTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Onconova Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Onconova Therapeutics, Inc.. Get notifications about new insider transactions in Onconova Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | SVP Corp Dev & Gen ... | Option Exercise | A | 1.51 | 208,000 | 314,080 | 208,000 | |
Feb 19 2021 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 1.51 | 301,000 | 454,510 | 301,000 | |
Feb 19 2021 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Ex ... | Option Exercise | A | 1.51 | 706,000 | 1,066,060 | 706,000 | |
Feb 17 2021 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | SVP Corp Dev & Gen ... | Buy | P | 1.00 | 12,000 | 12,000 | 152,000 | 140 K to 152 K (+8.57 %) |
Feb 17 2021 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Buy | P | 1.00 | 15,000 | 15,000 | 145,213 | 130.2 K to 145.2 K (+11.52 %) |
Feb 17 2021 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Ex ... | Buy | P | 1.00 | 20,000 | 20,000 | 236,226 | 216.2 K to 236.2 K (+9.25 %) |
Feb 17 2021 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Buy | P | 1.00 | 25,000 | 25,000 | 230,716 | 205.7 K to 230.7 K (+12.15 %) |
Feb 17 2021 | ONTX | Onconova Therapeut ... | Shoemaker Mary Teresa | Director | Buy | P | 1.00 | 13,000 | 13,000 | 50,735 | 37.7 K to 50.7 K (+34.45 %) |
Dec 14 2020 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | SVP Corp Dev & Gen ... | Buy | P | 0.32 | 30,000 | 9,600 | 140,000 | 110 K to 140 K (+27.27 %) |
Nov 30 2020 | ONTX | Onconova Therapeut ... | Shoemaker Mary Teresa | Director | Buy | P | 0.27 | 37,735 | 10,000 | 37,735 | 0 to 37.7 K |
Nov 30 2020 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Buy | P | 0.26 | 4,614 | 1,200 | 130,213 | 125.6 K to 130.2 K (+3.67 %) |
Nov 30 2020 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Buy | P | 0.26 | 16,755 | 4,356 | 125,599 | 108.8 K to 125.6 K (+15.39 %) |
Nov 30 2020 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | SVP Corp Dev & Gen ... | Buy | P | 0.26 | 20,000 | 5,120 | 110,000 | 90 K to 110 K (+22.22 %) |
Nov 30 2020 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Ex ... | Buy | P | 0.26 | 40,000 | 10,360 | 216,226 | 176.2 K to 216.2 K (+22.70 %) |
Nov 27 2020 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Buy | P | 0.26 | 38,774 | 10,004 | 205,716 | 166.9 K to 205.7 K (+23.23 %) |
Aug 31 2020 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Sell | S | 0.27 | 527,863 | 143,948 | 16,683 | 544.5 K to 16.7 K (-96.94 %) |
Aug 31 2020 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Sell | S | 0.27 | 1,876 | 510 | 0 | 1.9 K to 0 (-100.00 %) |
Aug 31 2020 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Sell | S | 0.27 | 182,492 | 49,620 | 21,919 | 204.4 K to 21.9 K (-89.28 %) |
Jul 10 2020 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | SVP Corp Dev & Gen ... | Option Exercise | A | 0.56 | 375,600 | 210,336 | 375,600 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 0.56 | 543,000 | 304,080 | 543,000 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | Woodman Richard Charles | Chief Medical Offic ... | Option Exercise | A | 0.56 | 396,000 | 221,760 | 396,000 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | Maniar Manoj | SVP - Product Devel ... | Option Exercise | A | 0.56 | 418,600 | 234,416 | 418,600 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | Shoemaker Mary Teresa | Director | Option Exercise | A | 0.56 | 125,000 | 70,000 | 125,000 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Ex ... | Option Exercise | A | 0.56 | 1,273,800 | 713,328 | 1,273,800 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | STOVER JACK E | Director | Option Exercise | A | 0.56 | 125,000 | 70,000 | 125,000 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Option Exercise | A | 0.56 | 125,000 | 70,000 | 125,000 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | MEHTA VIREN | Director | Option Exercise | A | 0.56 | 125,000 | 70,000 | 125,000 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | A | 0.56 | 125,000 | 70,000 | 125,000 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Option Exercise | A | 0.56 | 125,000 | 70,000 | 125,000 | |
Jul 10 2020 | ONTX | Onconova Therapeut ... | GROOPMAN JEROME | Director | Option Exercise | A | 0.56 | 125,000 | 70,000 | 125,000 | |
May 21 2020 | ONTX | Onconova Therapeut ... | GROOPMAN JEROME | Director | Buy | P | 0.36 | 10,000 | 3,626 | 10,001 | 1 to 10 K (+1,000,000.00 %) |
May 20 2020 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | SVP Corp Dev & Gen ... | Buy | P | 0.37 | 15,000 | 5,550 | 90,000 | 75 K to 90 K (+20.00 %) |
May 20 2020 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Buy | P | 0.36 | 21,000 | 7,560 | 108,844 | 87.8 K to 108.8 K (+23.91 %) |
May 20 2020 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Ex ... | Buy | P | 0.37 | 26,800 | 9,857 | 176,226 | 149.4 K to 176.2 K (+17.94 %) |
Dec 26 2019 | ONTX | Onconova Therapeut ... | Woodman Richard Charles | Chief Medical Offic ... | Option Exercise | A | 0.31 | 80,000 | 24,800 | 80,000 | |
Dec 26 2019 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | VP Corp Dev & Gen C ... | Option Exercise | A | 0.31 | 60,000 | 18,600 | 60,000 | |
Dec 26 2019 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Ex ... | Option Exercise | A | 0.31 | 200,000 | 62,000 | 200,000 | |
Dec 26 2019 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 0.31 | 65,000 | 20,150 | 65,000 | |
Dec 26 2019 | ONTX | Onconova Therapeut ... | Maniar Manoj | SVP - Product Devel ... | Option Exercise | A | 0.31 | 43,000 | 13,330 | 43,000 | |
Nov 27 2019 | ONTX | Onconova Therapeut ... | MEHTA VIREN | Director | Option Exercise | P | 0.20 | 250,000 | 50,000 | 250,000 | |
Nov 27 2019 | ONTX | Onconova Therapeut ... | MEHTA VIREN | Director | Buy | P | 0.20 | 250,000 | 50,000 | 250,857 | 857 to 250.9 K (+29,171.53 %) |
Nov 26 2019 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Option Exercise | P | 0.20 | 500,000 | 100,000 | 500,000 | |
Nov 26 2019 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Buy | P | 0.20 | 500,000 | 100,000 | 544,546 | 44.5 K to 544.5 K (+1,122.44 %) |
Nov 26 2019 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | P | 0.20 | 150,000 | 30,000 | 150,000 | |
Nov 26 2019 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Buy | P | 0.20 | 150,000 | 30,000 | 166,942 | 16.9 K to 166.9 K (+885.37 %) |
Nov 26 2019 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Ex ... | Option Exercise | P | 0.20 | 149,000 | 29,800 | 149,000 | |
Nov 26 2019 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Ex ... | Buy | P | 0.20 | 149,000 | 29,800 | 149,426 | 426 to 149.4 K (+34,976.53 %) |
Nov 26 2019 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | P | 0.20 | 87,500 | 17,500 | 87,500 | |
Nov 26 2019 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Buy | P | 0.20 | 87,500 | 17,500 | 87,844 | 344 to 87.8 K (+25,436.05 %) |
Nov 26 2019 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | VP Corp Dev & Gen C ... | Option Exercise | P | 0.20 | 75,000 | 15,000 | 75,000 | |
Nov 26 2019 | ONTX | Onconova Therapeut ... | OLER ABRAHAM N. | VP Corp Dev & Gen C ... | Buy | P | 0.20 | 75,000 | 15,000 | 75,000 | 0 to 75 K |
Sep 26 2019 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | P | 0.11 | 1,473 | 157 | 1,473 | |
Sep 26 2019 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | H | 0.43 | 1,473 | 626 | 0 | |
Sep 26 2019 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | P | 0.11 | 5,000 | 534 | 5,000 | |
Sep 26 2019 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | H | 1.01 | 5,000 | 5,050 | 0 | |
Sep 26 2019 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Buy | P | 1.60 | 7,260 | 11,616 | 16,942 | 9.7 K to 16.9 K (+74.98 %) |
Sep 26 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 1.19 | 16,700 | 19,873 | 616,389 | 633.1 K to 616.4 K (-2.64 %) |
Sep 25 2019 | ONTX | Onconova Therapeut ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 1.27 | 10,249 | 13,016 | 816,702 | 827 K to 816.7 K (-1.24 %) |
Sep 24 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 1.23 | 37,242 | 45,968 | 633,089 | 670.3 K to 633.1 K (-5.56 %) |
Sep 24 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 1.62 | 75,119 | 121,430 | 670,331 | 745.5 K to 670.3 K (-10.08 %) |
Sep 20 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 2.10 | 49,995 | 105,014 | 745,450 | 795.4 K to 745.5 K (-6.29 %) |
Sep 20 2019 | ONTX | Onconova Therapeut ... | 683 Capital Management, LLC | Sell | S | 2.20 | 1,533 | 3,376 | 460,000 | 461.5 K to 460 K (-0.33 %) | |
Sep 20 2019 | ONTX | Onconova Therapeut ... | 683 Capital Management, LLC | Sell | S | 1.82 | 120,000 | 218,184 | 461,533 | 581.5 K to 461.5 K (-20.64 %) | |
Sep 20 2019 | ONTX | Onconova Therapeut ... | 683 Capital Management, LLC | Sell | S | 2.18 | 173,332 | 377,448 | 581,533 | 754.9 K to 581.5 K (-22.96 %) | |
Sep 20 2019 | ONTX | Onconova Therapeut ... | 683 Capital Management, LLC | Sell | S | 1.86 | 93,286 | 173,139 | 754,865 | 848.2 K to 754.9 K (-11.00 %) | |
Sep 20 2019 | ONTX | Onconova Therapeut ... | 683 Capital Management, LLC | Sell | S | 2.18 | 118,726 | 258,538 | 848,151 | 966.9 K to 848.2 K (-12.28 %) | |
Sep 13 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 2.75 | 1,247 | 3,432 | 795,445 | 796.7 K to 795.4 K (-0.16 %) |
Sep 11 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 2.77 | 400 | 1,106 | 796,692 | 797.1 K to 796.7 K (-0.05 %) |
Sep 09 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 2.78 | 5,015 | 13,954 | 797,092 | 802.1 K to 797.1 K (-0.63 %) |
Sep 09 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 2.75 | 400 | 1,100 | 802,107 | 802.5 K to 802.1 K (-0.05 %) |
Jul 29 2019 | ONTX | Onconova Therapeut ... | GROOPMAN JEROME | Director | Option Exercise | A | 3.39 | 5,833 | 19,774 | 5,833 | |
Jul 29 2019 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Option Exercise | A | 3.39 | 5,833 | 19,774 | 5,833 | |
Jul 29 2019 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | A | 3.39 | 5,833 | 19,774 | 5,833 | |
Jul 29 2019 | ONTX | Onconova Therapeut ... | MEHTA VIREN | Director | Option Exercise | A | 3.39 | 5,833 | 19,774 | 5,833 | |
Jul 29 2019 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Option Exercise | A | 3.39 | 5,833 | 19,774 | 5,833 | |
Jul 29 2019 | ONTX | Onconova Therapeut ... | STOVER JACK E | Director | Option Exercise | A | 3.39 | 5,833 | 19,774 | 5,833 | |
Jul 11 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 2.81 | 2,742 | 7,697 | 802,507 | 805.2 K to 802.5 K (-0.34 %) |
Jul 11 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 2.84 | 8,185 | 23,204 | 805,249 | 813.4 K to 805.2 K (-1.01 %) |
Jul 01 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 3.45 | 1,458 | 5,025 | 813,434 | 814.9 K to 813.4 K (-0.18 %) |
Jun 27 2019 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sell | S | 3.40 | 1,380 | 4,689 | 814,892 | 816.3 K to 814.9 K (-0.17 %) |
Apr 08 2019 | ONTX | Onconova Therapeut ... | Maniar Manoj | SVP - Product Devel ... | Option Exercise | A | 3.41 | 5,000 | 17,050 | 5,000 | |
Nov 07 2018 | ONTX | Onconova Therapeut ... | Woodman Richard Charles | Chief Medical Offic ... | Option Exercise | A | 5.82 | 20,000 | 116,400 | 20,000 | |
Aug 29 2018 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Sell | S | 0.45 | 29,999 | 13,521 | 5,731,117 | 5.8 M to 5.7 M (-0.52 %) |
Aug 29 2018 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Sell | S | 0.46 | 30,000 | 13,707 | 5,761,116 | 5.8 M to 5.8 M (-0.52 %) |
Aug 29 2018 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Sell | S | 0.44 | 20,000 | 8,890 | 5,791,116 | 5.8 M to 5.8 M (-0.34 %) |
Aug 29 2018 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Sell | S | 0.45 | 20,000 | 9,070 | 5,811,116 | 5.8 M to 5.8 M (-0.34 %) |
Jul 30 2018 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Option Exercise | A | 0.46 | 87,500 | 40,250 | 87,500 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | A | 0.46 | 87,500 | 40,250 | 87,500 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | STOVER JACK E | Director | Option Exercise | A | 0.46 | 87,500 | 40,250 | 87,500 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | MEHTA VIREN | Director | Option Exercise | A | 0.46 | 87,500 | 40,250 | 87,500 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Option Exercise | A | 0.46 | 87,500 | 40,250 | 87,500 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | GROOPMAN JEROME | Director | Option Exercise | A | 0.46 | 87,500 | 40,250 | 87,500 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 0.46 | 384,950 | 177,077 | 384,950 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | Kumar Ramesh | Chief Executive Off ... | Option Exercise | A | 0.46 | 1,065,600 | 490,176 | 1,065,600 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | President, Chief Me ... | Option Exercise | A | 0.46 | 400,000 | 184,000 | 400,000 | |
Jul 30 2018 | ONTX | Onconova Therapeut ... | Maniar Manoj | SVP - Product Devel ... | Option Exercise | A | 0.46 | 300,000 | 138,000 | 300,000 | |
May 31 2018 | ONTX | Onconova Therapeut ... | Bienen Henry S | Director | Buy | P | 0.38 | 10,000 | 3,800 | 22,724 | 12.7 K to 22.7 K (+78.59 %) |
May 01 2018 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Option Exercise | P | 0.43 | 282,350 | 119,999 | 282,350 | |
May 01 2018 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Buy | P | 0.00 | 282,350 | 0 | 668,182 | 385.8 K to 668.2 K (+73.18 %) |
May 01 2018 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Option Exercise | P | 0.43 | 2,211,765 | 940,000 | 2,211,765 | |
May 01 2018 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Buy | P | 0.00 | 2,211,765 | 0 | 3,192,438 | 980.7 K to 3.2 M (+225.54 %) |
May 01 2018 | ONTX | Onconova Therapeut ... | STOVER JACK E | Director | Option Exercise | P | 0.43 | 47,100 | 20,018 | 47,100 | |
May 01 2018 | ONTX | Onconova Therapeut ... | STOVER JACK E | Director | Buy | P | 0.00 | 47,100 | 0 | 47,110 | 10 to 47.1 K (+471,000.00 %) |
May 01 2018 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | P | 0.43 | 58,900 | 25,033 | 58,900 | |
May 01 2018 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Buy | P | 0.00 | 58,900 | 0 | 145,221 | 86.3 K to 145.2 K (+68.23 %) |
May 01 2018 | ONTX | Onconova Therapeut ... | 683 Capital Management, LLC | 10% Owner | Buy | P | 0.43 | 11,838,235 | 5,031,250 | 14,503,169 | 2.7 M to 14.5 M (+444.22 %) |
May 01 2018 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Option Exercise | P | 0.43 | 10,147,058 | 4,312,500 | 10,147,058 | |
May 01 2018 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Buy | P | 0.43 | 10,147,058 | 4,312,500 | 12,244,080 | 2.1 M to 12.2 M (+483.88 %) |
Feb 27 2018 | ONTX | Onconova Therapeut ... | Kumar Ramesh | President and CEO | Option Exercise | A | 1.09 | 73,220 | 79,810 | 73,220 | |
Feb 12 2018 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Option Exercise | P | 1.01 | 1,100,000 | 1,111,000 | 1,100,000 | |
Feb 12 2018 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Buy | P | 1.01 | 1,100,000 | 1,111,000 | 2,097,022 | 997 K to 2.1 M (+110.33 %) |
Feb 12 2018 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | P | 1.01 | 50,000 | 50,500 | 50,000 | |
Feb 12 2018 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Buy | P | 0.00 | 50,000 | 0 | 86,321 | 36.3 K to 86.3 K (+137.66 %) |
Feb 12 2018 | ONTX | Onconova Therapeut ... | 683 Capital Management, LLC | 10% Owner | Buy | P | 1.04 | 200,000 | 207,120 | 2,664,934 | 2.5 M to 2.7 M (+8.11 %) |
Jan 05 2018 | ONTX | Onconova Therapeut ... | Kumar Ramesh | President and CEO | Option Exercise | A | 1.50 | 64,885 | 97,328 | 64,885 | |
Jan 05 2018 | ONTX | Onconova Therapeut ... | Maniar Manoj | SVP - Product Devel ... | Option Exercise | A | 1.50 | 28,609 | 42,914 | 28,609 | |
Jan 05 2018 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | Chief Medical Offic ... | Option Exercise | A | 1.50 | 43,627 | 65,441 | 43,627 | |
Jan 05 2018 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 1.50 | 31,024 | 46,536 | 31,024 | |
Jun 13 2017 | ONTX | Onconova Therapeut ... | Bienen Henry S | Director | Option Exercise | A | 1.94 | 1,500 | 2,910 | 1,500 | |
Jun 13 2017 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Option Exercise | A | 1.94 | 2,000 | 3,880 | 2,000 | |
Jun 13 2017 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Option Exercise | A | 1.94 | 1,500 | 2,910 | 1,500 | |
Jun 13 2017 | ONTX | Onconova Therapeut ... | MEHTA VIREN | Director | Option Exercise | A | 1.94 | 1,500 | 2,910 | 1,500 | |
Jun 13 2017 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Option Exercise | A | 1.94 | 1,500 | 2,910 | 1,500 | |
Jun 13 2017 | ONTX | Onconova Therapeut ... | STOVER JACK E | Director | Option Exercise | A | 1.94 | 1,500 | 2,910 | 1,500 | |
Jun 13 2017 | ONTX | Onconova Therapeut ... | GROOPMAN JEROME | Director | Option Exercise | A | 1.94 | 1,500 | 2,910 | 1,500 | |
Apr 28 2017 | ONTX | Onconova Therapeut ... | Bienen Henry S | Director | Buy | P | 2.10 | 3,810 | 8,001 | 12,724 | 8.9 K to 12.7 K (+42.74 %) |
Apr 28 2017 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Buy | P | 2.10 | 1,429 | 3,001 | 5,155 | 3.7 K to 5.2 K (+38.35 %) |
Apr 28 2017 | ONTX | Onconova Therapeut ... | MARINO JAMES J | Director | Buy | P | 2.10 | 11,906 | 25,003 | 36,321 | 24.4 K to 36.3 K (+48.77 %) |
Apr 28 2017 | ONTX | Onconova Therapeut ... | Reddy E Premkumar | Director | Buy | P | 2.10 | 119,048 | 250,001 | 385,832 | 266.8 K to 385.8 K (+44.62 %) |
Apr 28 2017 | ONTX | Onconova Therapeut ... | Kumar Ramesh | President and CEO | Buy | P | 2.10 | 23,810 | 50,001 | 102,227 | 78.4 K to 102.2 K (+30.36 %) |
Apr 24 2017 | ONTX | Onconova Therapeut ... | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Grant | A | 2.10 | 476,190 | 999,999 | 997,022 | 520.8 K to 997 K (+91.43 %) |
Jan 19 2017 | ONTX | Onconova Therapeut ... | Maniar Manoj | SVP - Product Devel ... | Option Exercise | A | 2.70 | 19,413 | 52,415 | 19,413 | |
Jan 19 2017 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 2.70 | 19,413 | 52,415 | 19,413 | |
Jan 19 2017 | ONTX | Onconova Therapeut ... | Kumar Ramesh | President and CEO | Option Exercise | A | 2.70 | 44,027 | 118,873 | 44,027 | |
Jan 19 2017 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | Chief Medical Offic ... | Option Exercise | A | 2.70 | 26,401 | 71,283 | 26,401 | |
Dec 19 2016 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | Chief Medical Offic ... | Option Exercise | A | 2.65 | 7,599 | 20,137 | 7,599 | |
Dec 19 2016 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 2.65 | 5,587 | 14,806 | 5,587 | |
Dec 19 2016 | ONTX | Onconova Therapeut ... | Kumar Ramesh | President and CEO | Option Exercise | A | 2.65 | 12,673 | 33,583 | 12,673 | |
Dec 19 2016 | ONTX | Onconova Therapeut ... | Maniar Manoj | SVP - Product Devel ... | Option Exercise | A | 2.65 | 5,587 | 14,806 | 5,587 | |
Sep 01 2016 | ONTX | Onconova Therapeut ... | Kumar Ramesh | President and CEO | Option Exercise | A | 3.24 | 44,000 | 142,560 | 44,000 | |
Sep 01 2016 | ONTX | Onconova Therapeut ... | Maniar Manoj | SVP - Product Devel ... | Option Exercise | A | 3.24 | 17,000 | 55,080 | 17,000 | |
Sep 01 2016 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 3.24 | 5,000 | 16,200 | 5,000 | |
Sep 01 2016 | ONTX | Onconova Therapeut ... | Guerin Mark Patrick | Chief Financial Off ... | Option Exercise | A | 3.24 | 10,000 | 32,400 | 10,000 | |
Sep 01 2016 | ONTX | Onconova Therapeut ... | Fruchtman Steven M | Chief Medical Offic ... | Option Exercise | A | 3.24 | 25,000 | 81,000 | 25,000 | |
Aug 10 2016 | ONTX | Onconova Therapeut ... | Bienen Henry S | Director | Option Exercise | X | 4.92 | 5,564 | 27,375 | 5,564 | |
Aug 10 2016 | ONTX | Onconova Therapeut ... | Bienen Henry S | Director | Option Exercise | X | 4.10 | 2,241 | 9,188 | 0 | |
Aug 10 2016 | ONTX | Onconova Therapeut ... | Bienen Henry S | Director | Buy | X | 4.10 | 7,420 | 30,422 | 8,914 | 1.5 K to 8.9 K (+496.65 %) |
Aug 10 2016 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Option Exercise | X | 4.92 | 396,633 | 1,951,434 | 396,633 | |
Aug 10 2016 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Option Exercise | X | 4.10 | 528,845 | 2,168,265 | 0 | |
Aug 10 2016 | ONTX | Onconova Therapeut ... | Hoffman Michael B | Director | Buy | X | 4.10 | 528,845 | 2,168,265 | 980,673 | 451.8 K to 980.7 K (+117.05 %) |